IDT Australia Ltd (ASX: IDT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
IDT Australia Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
IDT Australia Ltd (ASX: IDT)
Latest News
Healthcare Shares
How did ASX biotech shares perform in FY22?
Healthcare Shares
Why the IDT Australia (ASX:IDT) share price is crashing 37% lower today
Healthcare Shares
Why is the IDT (ASX:IDT) share price halted today?
Healthcare Shares
IDT (ASX:IDT) share price swings as CEO lauds mRNA tech in fight against Omicron
Share Market News
The Starpharma (ASX: SPL) share price surges on Vietnam launch
Healthcare Shares
IDT Australia (ASX:IDT) share price rockets 40% on COVID vaccine update
Share Gainers
Here's why the IDT Australia (ASX:IDT) share price is up 75% in a month.
Share Gainers
IDT Australia (ASX: IDT) share price surges 16% on vaccine government talks
Healthcare Shares
Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday
Share Gainers
Why the IDT Australia (ASX:IDT) share price is storming 19% higher today
Share Gainers
Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days
Share Market News
Why COVID-19 is launching the IDT Australia (ASX:IDT) share price 65%
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 08 May 2006 | $0.0350 | 100.00% | Interim | 26 May 2006 |
| 30 Sep 2005 | $0.0450 | 100.00% | Final | 21 Oct 2005 |
| 08 Apr 2004 | $0.0300 | 100.00% | Interim | 30 Apr 2004 |
IDT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About IDT Australia Ltd
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
IDT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Feb 2026 | $0.05 | $0.00 | 0.00% | 188,096 | $0.05 | $0.05 | $0.05 |
| 05 Feb 2026 | $0.05 | $0.00 | 0.00% | 5,750 | $0.05 | $0.05 | $0.05 |
| 04 Feb 2026 | $0.05 | $0.00 | 0.00% | 55,846 | $0.05 | $0.05 | $0.05 |
| 02 Feb 2026 | $0.05 | $0.00 | 0.00% | 1,241,606 | $0.05 | $0.05 | $0.05 |
| 30 Jan 2026 | $0.05 | $0.00 | 0.00% | 1,038,903 | $0.05 | $0.05 | $0.05 |
| 29 Jan 2026 | $0.05 | $0.00 | 0.00% | 155,807 | $0.05 | $0.05 | $0.05 |
| 28 Jan 2026 | $0.05 | $0.00 | 0.00% | 264 | $0.05 | $0.05 | $0.05 |
| 27 Jan 2026 | $0.05 | $0.00 | 0.00% | 119,000 | $0.05 | $0.05 | $0.05 |
| 23 Jan 2026 | $0.05 | $0.00 | 0.00% | 114,864 | $0.05 | $0.05 | $0.05 |
| 22 Jan 2026 | $0.05 | $0.00 | 0.00% | 434,212 | $0.05 | $0.05 | $0.05 |
| 21 Jan 2026 | $0.05 | $0.00 | 0.00% | 175 | $0.05 | $0.05 | $0.05 |
| 20 Jan 2026 | $0.05 | $0.00 | 0.00% | 260,417 | $0.05 | $0.05 | $0.05 |
| 19 Jan 2026 | $0.05 | $0.00 | 0.00% | 31,822 | $0.05 | $0.05 | $0.05 |
| 16 Jan 2026 | $0.05 | $0.00 | 0.00% | 69,584 | $0.05 | $0.05 | $0.05 |
| 15 Jan 2026 | $0.05 | $0.00 | 0.00% | 23,034 | $0.05 | $0.05 | $0.05 |
| 14 Jan 2026 | $0.05 | $0.00 | 0.00% | 90,629 | $0.05 | $0.05 | $0.05 |
| 13 Jan 2026 | $0.05 | $0.00 | 0.00% | 1,650 | $0.05 | $0.05 | $0.05 |
| 12 Jan 2026 | $0.05 | $0.00 | 0.00% | 7,721 | $0.05 | $0.05 | $0.05 |
| 09 Jan 2026 | $0.05 | $0.00 | 0.00% | 62,327 | $0.05 | $0.05 | $0.05 |
| 08 Jan 2026 | $0.05 | $0.00 | 0.00% | 127,356 | $0.05 | $0.05 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 04 Dec 2025 | Geoffrey Sam | Buy | 98,039 | $5,098 |
On-market trade.
|
| 10 Apr 2025 | Geoffrey Sam | Buy | 228,015 | $22,801 |
On-market trade.
|
| 09 Apr 2025 | Geoffrey Sam | Buy | 20,617 | $2,020 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Mark Anthony Simari | Non-Executive DirectorNon-Executive Chairman | Oct 2022 |
Mr Simari is an experienced and accomplished professional in the health industry and has over 15 years of Board experience in a diverse range of organizations. He was involved in Paragon Care becoming an independent healthcare supplier in the Australian and New Zealand Markets, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. Non-Executive Chairman of the Board and a Member of the Risk Committee.
|
| Mr Geoffrey Joseph Sam | Non-Executive Director | Oct 2022 |
Mr Sam is currently the Chairperson and has also held previous independent Non-executive Board positions with listed companies Money 3 Ltd, Hutchinsons Childcare Services Ltd and was Managing Director of Nova Health Ltd. He is the Co-Founder and Board member of Healthe Care Australia Pty Ltd, a privately owned health care company comprising a portfolio of 18 hospitals. He is Chair of the Risk Committee.
|
| Dr Jane Ryan | Non-Executive Director | Jan 2022 |
Dr Ryan has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked in Australia, the United States and United Kingdom. Throughout her career, she has led many fundraising campaigns and licensing initiatives including the winning of a $230 million US Government contract. He is a Member of the Risk Committee.
|
| Mr Mark Andrew Licciardo | Company Secretary | Oct 2022 |
-
|
| Mr Paul Joseph Mcdonald | Chief Executive Officer | Sep 2022 |
-
|
| Paul Joseph Mcdonald | Chief Executive Officer |
-
|
|
| Vasanthakumar | Chief Financial Officer |
-
|
|
| J Sosic | Chief Operating Officer |
-
|
|
| Mark Andrew Licciardo | Company Secretary |
-
|
|
| M Flanders | Director of Commercial & Business Development |
-
|
|
| M Thompson | Director of Commercial & Business Development |
-
|
|
| R Caunce | Director of Quality |
-
|
|
| P Coutts | Head of People & Safety |
-
|
|
| P Thiyageas | Quality Director |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| One Managed Invt Funds Ltd Sandon Capital Inv Ltd A/C | 48,283,127 | 11.39% |
| HSBC Custody Nominees (Australia) Limited | 35,934,779 | 8.47% |
| Citicorp Nominees Pty Limited | 33,220,721 | 7.83% |
| One Fund Services Ltd Sandon Capital Activist A/C | 29,043,707 | 6.85% |
| UBS Nominees Pty Ltd | 28,827,545 | 6.80% |
| Mr Anthony John Huntley | 11,600,000 | 2.74% |
| Mr Robert Darius Fraser Fraser Family A/C | 11,278,752 | 2.66% |
| Keiser Investments Pty Ltd Gann Family Retirement A/C | 7,435,523 | 1.75% |
| On On For Don Pty Ltd Mac Family A/C | 6,700,000 | 1.58% |
| Picherit'S Farm Pty Ltd Huntley Super Fund A/C | 6,500,000 | 1.53% |
| Invia Custodian Pty Limited Graeme Leslie Blackman A/C | 6,029,710 | 1.42% |
| J P Morgan Nominees Australia Pty Limited | 5,078,928 | 1.20% |
| Mr Edmond Wing Kin Cheung & Mrs Eliza Siu Ling Cheung Edmond & Eliza S/F A/C | 4,929,147 | 1.16% |
| Rossbow Pty Ltd Andrew Macpherson Tdt A/C | 4,050,000 | 0.96% |
| Ms Melissa Mary Stephens | 4,000,000 | 0.94% |
| Laicos Securities Pty Ltd | 4,000,000 | 0.94% |
| Mr Alistair David Strong | 3,880,352 | 0.92% |
| Luton Pty Ltd | 3,638,889 | 0.86% |
| Jasbaat Super Pty Ltd | 3,490,663 | 0.82% |
| Invia Custodian Pty Limited Paulene Blackman A/C | 3,457,737 | 0.82% |